Telomir Pharmaceuticals
(NASDAQ) TELO
Telomir Pharmaceuticals Financials at a Glance
Market Cap
$45.38M
Revenue (TTM)
$0.00
Net Income (TTM)
$10.41M
EPS (TTM)
$-0.34
P/E Ratio
-3.93
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$1.32
Volume
42,545.199
Open
$1.29
Price
$1.32
Volume
42,545.199
Open
$1.29
Previous Close
$1.32
Daily Range
$1.27 - $1.32
52-Week Range
$1.05 - $4.80
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$1.32
Volume
42,545.199
Open
$1.29
Previous Close
$1.32
Daily Range
$1.27 - $1.32
52-Week Range
$1.05 - $4.80
TELO News
TELO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Telomir Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
2
CEO
Erez Aminov
Website
www.telomirpharma.comHeadquarters
Baltimore, FL 21205, US
TELO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-318%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-25.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$45.38M
Shares Outstanding
34.38M
Volume
42.55K
Short Interest
0.00%
Avg. Volume
141.00K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$10.54M
EBITDA
$10.54M
Operating Cash Flow
$3.69M
Capital Expenditure
$0.00
Free Cash Flow
$3.69M
Cash & ST Invst.
$7.29M
Total Debt
$0.00
Telomir Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$45.38M
N/A
Market Cap/Employee
$45.38M
N/A
Employees
1
N/A
Net Income
$2.06M
+28.9%
EBITDA
$2.13M
+26.3%
Quarterly Fundamentals
Net Cash
$7.29M
+521.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-1.42%
N/A
Return on Invested Capital
-1.78%
N/A
Free Cash Flow
$1.20M
-98.3%
Operating Cash Flow
$1.20M
-98.3%